請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33448
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳成文(Cheng-Wen Wu) | |
dc.contributor.author | Chia-Hui Lin | en |
dc.contributor.author | 林佳慧 | zh_TW |
dc.date.accessioned | 2021-06-13T04:41:05Z | - |
dc.date.available | 2006-08-03 | |
dc.date.copyright | 2006-08-03 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-18 | |
dc.identifier.citation | Alter, M. J. (1997). Epidemiology of hepatitis C. Hepatology 26, 62S-65S.
An, W., Kim, J. and Roeder, R. G. (2004). Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117, 735-48. Baeuerle, P. A. and Baltimore, D. (1988). I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-6. Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J., Miyamura, T. et al. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94, 1200-5. Bernat, A., Avvakumov, N., Mymryk, J. S. and Banks, L. (2003). Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 22, 7871-81. Bernstein, B. E., Humphrey, E. L., Erlich, R. L., Schneider, R., Bouman, P., Liu, J. S., Kouzarides, T. and Schreiber, S. L. (2002). Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A 99, 8695-700. Chakravarti, D., Ogryzko, V., Kao, H. Y., Nash, A., Chen, H., Nakatani, Y. and Evans, R. M. (1999). A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96, 393-403. Chen, C. H., Sheu, J. C., Wang, J. T., Huang, G. T., Yang, P. M., Lee, H. S., Lee, C. Z. and Chen, D. S. (1994). Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J Med Virol 44, 234-6. Chen, C. M., You, L. R., Hwang, L. H. and Lee, Y. H. (1997). Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor. J Virol 71, 9417-26. Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S. M., Schurter, B. T., Aswad, D. W. and Stallcup, M. R. (1999). Regulation of transcription by a protein methyltransferase. Science 284, 2174-7. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. and Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-62. Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., McKinney, K., Tempst, P., Prives, C., Gamblin, S. J. et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432, 353-60. Covic, M., Hassa, P. O., Saccani, S., Buerki, C., Meier, N. I., Lombardi, C., Imhof, R., Bedford, M. T., Natoli, G. and Hottiger, M. O. (2005). Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. Embo J 24, 85-96. Daujat, S., Zeissler, U., Waldmann, T., Happel, N. and Schneider, R. (2005). HP1 binds specifically to Lys26-methylated histone H1.4, whereas simultaneous Ser27 phosphorylation blocks HP1 binding. J Biol Chem 280, 38090-5. Davie, J. R. and Murphy, L. C. (1990). Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry 29, 4752-7. de Lucas, S., Bartolome, J., Amaro, M. J. and Carreno, V. (2003). Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-kappaB activation. Antiviral Res 60, 117-24. Deng, W. G., Zhu, Y. and Wu, K. K. (2003). Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J Biol Chem 278, 4770-7. Di Bisceglie, A. M. (1998). Hepatitis C. Lancet 351, 351-5. Dubourdeau, M., Miyamura, T., Matsuura, Y., Alric, L., Pipy, B. and Rousseau, D. (2002). Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. J Hepatol 37, 486-92. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-25. Gary, J. D. and Clarke, S. (1998). RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61, 65-131. Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225-60. Gomez-Gonzalo, M., Benedicto, I., Carretero, M., Lara-Pezzi, E., Maldonado-Rodriguez, A., Moreno-Otero, R., Lai, M. M. and Lopez-Cabrera, M. (2004). Hepatitis C virus core protein regulates p300/CBP co-activation function. Possible role in the regulation of NF-AT1 transcriptional activity. Virology 328, 120-30. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M. and Rice, C. M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-95. Grunstein, M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-52. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-16. Hijikata, M., Kato, N., Ootsuyama, Y., Nakagawa, M. and Shimotohno, K. (1991). Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 88, 5547-51. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. (1991). p53 mutations in human cancers. Science 253, 49-53. Hsieh, T. Y., Matsumoto, M., Chou, H. C., Schneider, R., Hwang, S. B., Lee, A. S. and Lai, M. M. (1998). Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem 273, 17651-9. Hsu, C. H., Chang, M. D., Tai, K. Y., Yang, Y. T., Wang, P. S., Chen, C. J., Wang, Y. H., Lee, S. C., Wu, C. W. and Juan, L. J. (2004). HCMV IE2-mediated inhibition of HAT activity downregulates p53 function. Embo J 23, 2269-80. Jenuwein, T. and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-80. Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S. and Christman, J. W. (2005). Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol 79, 7648-57. Kao, C. F., Chen, S. Y., Chen, J. Y. and Wu Lee, Y. H. (2004). Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23, 2472-83. Kao, J. H., Chen, P. J., Lai, M. Y., Yang, P. M., Sheu, J. C., Wang, T. H. and Chen, D. S. (1995). Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J Clin Gastroenterol 21, 233-7. Karin, M. (1998). The NF-kappa B activation pathway: its regulation and role in inflammation and cell survival. Cancer J Sci Am 4 Suppl 1, S92-9. Kornberg, R. D. and Lorch, Y. (1999). Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98, 285-94. Kuzmichev, A., Jenuwein, T., Tempst, P. and Reinberg, D. (2004). Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell 14, 183-93. Lee, D. Y., Hayes, J. J., Pruss, D. and Wolffe, A. P. (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73-84. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-31. Li, Y. J., Stallcup, M. R. and Lai, M. M. (2004). Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol 78, 13325-34. Lim, S. P. and Garzino-Demo, A. (2000). The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites. J Virol 74, 1632-40. Lin, W. J., Gary, J. D., Yang, M. C., Clarke, S. and Herschman, H. R. (1996). The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem 271, 15034-44. Liu, Q., Tackney, C., Bhat, R. A., Prince, A. M. and Zhang, P. (1997). Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 71, 657-62. Lo, S. Y., Masiarz, F., Hwang, S. B., Lai, M. M. and Ou, J. H. (1995). Differential subcellular localization of hepatitis C virus core gene products. Virology 213, 455-61. Lo, S. Y., Selby, M., Tong, M. and Ou, J. H. (1994). Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 199, 124-31. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. and Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-3. Lu, W., Lo, S. Y., Chen, M., Wu, K., Fung, Y. K. and Ou, J. H. (1999). Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264, 134-41. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. and Richmond, T. J. (1997). Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389, 251-60. Marusawa, H., Hijikata, M., Chiba, T. and Shimotohno, K. (1999). Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 73, 4713-20. Matsumoto, M., Hsieh, T. Y., Zhu, N., VanArsdale, T., Hwang, S. B., Jeng, K. S., Gorbalenya, A. E., Lo, S. Y., Ou, J. H., Ware, C. F. et al. (1997). Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol 71, 1301-9. Moradpour, D., Englert, C., Wakita, T. and Wands, J. R. (1996). Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222, 51-63. Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T. and Koike, K. (1998). The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4, 1065-7. Mowen, K. A., Tang, J., Zhu, W., Schurter, B. T., Shuai, K., Herschman, H. R. and David, M. (2001). Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104, 731-41. Nelson, P. J., Kim, H. T., Manning, W. C., Goralski, T. J. and Krensky, A. M. (1993). Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151, 2601-12. Nielsen, S. J., Schneider, R., Bauer, U. M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E. et al. (2001). Rb targets histone H3 methylation and HP1 to promoters. Nature 412, 561-5. Nishioka, K., Chuikov, S., Sarma, K., Erdjument-Bromage, H., Allis, C. D., Tempst, P. and Reinberg, D. (2002). Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16, 479-89. Nowak, S. J. and Corces, V. G. (2004). Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 20, 214-20. Okamoto, S., Mukaida, N., Yasumoto, K., Rice, N., Ishikawa, Y., Horiguchi, H., Murakami, S. and Matsushima, K. (1994). The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. J Biol Chem 269, 8582-9. Otsuka, M., Kato, N., Lan, K., Yoshida, H., Kato, J., Goto, T., Shiratori, Y. and Omata, M. (2000). Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 275, 34122-30. Patel, D., Huang, S. M., Baglia, L. A. and McCance, D. J. (1999). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. Embo J 18, 5061-72. Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A. et al. (2001). Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107, 323-37. Ralston, R., Thudium, K., Berger, K., Kuo, C., Gervase, B., Hall, J., Selby, M., Kuo, G., Houghton, M. and Choo, Q. L. (1993). Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 67, 6753-61. Ray, R. B., Lagging, L. M., Meyer, K. and Ray, R. (1996). Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70, 4438-43. Ray, R. B., Steele, R., Meyer, K. and Ray, R. (1998). Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208, 331-6. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M., Nainan, O. et al. (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143, 2493-503. Santolini, E., Migliaccio, G. and La Monica, N. (1994). Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 68, 3631-41. Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C., Schreiber, S. L., Mellor, J. and Kouzarides, T. (2002). Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-11. Schurter, B. T., Koh, S. S., Chen, D., Bunick, G. J., Harp, J. M., Hanson, B. L., Henschen-Edman, A., Mackay, D. R., Stallcup, M. R. and Aswad, D. W. (2001). Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 40, 5747-56. Selby, M. J., Choo, Q. L., Berger, K., Kuo, G., Glazer, E., Eckart, M., Lee, C., Chien, D., Kuo, C. and Houghton, M. (1993). Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 74 (Pt 6), 1103-13. Shih, C. M., Chen, C. M., Chen, S. Y. and Lee, Y. H. (1995). Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69, 1160-71. Shrivastava, A., Manna, S. K., Ray, R. and Aggarwal, B. B. (1998). Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol 72, 9722-8. Somasundaram, K. and El-Deiry, W. S. (1997). Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-57. Sun, C. A., Chen, H. C., Lu, C. F., You, S. L., Mau, Y. C., Ho, M. S., Lin, S. H. and Chen, C. J. (1999). Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 59, 290-6. Suzuki, R., Sakamoto, S., Tsutsumi, T., Rikimaru, A., Tanaka, K., Shimoike, T., Moriishi, K., Iwasaki, T., Mizumoto, K., Matsuura, Y. et al. (2005). Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 79, 1271-81. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M. et al. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-6. Wang, H., Cao, R., Xia, L., Erdjument-Bromage, H., Borchers, C., Tempst, P. and Zhang, Y. (2001a). Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8, 1207-17. Wang, H., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P. et al. (2001b). Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293, 853-7. Wu, J. S., Lee, H. F., Hsiau, H. L., Lu, H. Y., Chou, W. H., Lu, C. F., Chen, H. Y., Lee, F. N., Chen, P. Y. and Tam, K. M. (1994). Genotype distribution of hepatitis C virus infection in Taiwan. J Med Virol 44, 74-9. Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S. I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J. R. and Kohara, M. (1998). The native form and maturation process of hepatitis C virus core protein. J Virol 72, 6048-55. Yoshida, H., Kato, N., Shiratori, Y., Otsuka, M., Maeda, S., Kato, J. and Omata, M. (2001). Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 276, 16399-405. Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K., Sata, M., Kohara, M. and Yoshimura, A. (2002). Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 196, 641-53. You, L. R., Chen, C. M. and Lee, Y. H. (1999). Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 73, 1672-81. You, L. R., Chen, C. M., Yeh, T. S., Tsai, T. Y., Mai, R. T., Lin, C. H. and Lee, Y. H. (1999). Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 73, 2841-53. Zhang, Y. and Reinberg, D. (2001). Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15, 2343-60. Zhu, N., Khoshnan, A., Schneider, R., Matsumoto, M., Dennert, G., Ware, C. and Lai, M. M. (1998). Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72, 3691-7. Zignego, A. L., Macchia, D., Monti, M., Thiers, V., Mazzetti, M., Foschi, M., Maggi, E., Romagnani, S., Gentilini, P. and Brechot, C. (1992). Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15, 382-6. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33448 | - |
dc.description.abstract | C 型肝炎病毒感染在台灣已經成為慢性肝炎以及肝癌的主要致病原因,然而其致病機制並不清楚。核心蛋白為C 型肝炎病毒的結構蛋白,已被發現能調節許多細胞訊息傳遞路徑以及轉錄因子功能,並能於基因轉殖鼠內造成肝癌。因此,核心蛋白與細胞中分子的相互作用在致病機制中很可能扮演著重要的角色。在此篇論文中,我們探討了C型肝炎病毒核心蛋白對組蛋白甲基化酵素活性的調控。甲基化酵素為染色質修飾蛋白之一,而染色質修飾蛋白是由轉錄因子將其帶到基因的啟動子(promoter)對組蛋白進行修飾,使基因活化或抑制其表現。
利用組蛋白甲基化實驗(histone methyltransferase assay) ,我們發現C型肝炎病毒核心蛋白在試管內能抑制組蛋白甲基化酵素CARM1、PRMT1及SET9對組蛋白H3/H4的活性。核心蛋白本身亦能被CARM1及PRMT1進行甲基化,而SET9對於組蛋白H1的活性反而受核心蛋白影響而增加。利用核心蛋白的缺失突變,我們發現胺基酸51到101的片段對於核心蛋白抑制甲基化酵素是不可缺少的。目前已有許多報導指出C型肝炎病毒核心蛋白能調控細胞內許多轉錄因子如p53和NF-κB。我們的實驗發現核心蛋白會被帶到具有NF-κB結合位置的DNA上。利用luciferase assay,在HuH-7細胞中一些NF-κB下游基因Cox-2、IL-8、MCP-1 及 RANTES其啟動子的活性皆會被核心蛋白所抑制。而目前已知這三個甲基化酵素皆為p53的輔激活蛋白而CARM1在最近也被發現為NF-κB的輔激活蛋白。GST pull-down實驗的結果告訴我們全長的核心蛋白與細胞內的NF-κB組成分子p65、CARM1、PRMT1以及SET9有交互作用。此外,在HuH-7細胞中,核心蛋白的另一個目標基因—p53下游基因p21其啟動子活性也會受到核心蛋白所抑制。由chromatin immunoprecipitation實驗的結果,我們發現在HuH-7細胞中,在p21啟動子上,核心蛋白會減少CARM1以及PRMT1對其標的組蛋白精胺酸位置的甲基化。 總而言之,C型肝炎病毒核心蛋白抑制NF-κB及p53下游基因可能是經由抑制NF-κB及p53輔激活蛋白CARM1、PRMT1及SET9對組蛋白H3/H4的活性。我們的研究提供了一個C型肝炎病毒核心蛋白調控NF-κB和p53活性的新機制。其他受甲基化酵素調控的路徑亦可能會受到核心蛋白的影響。 | zh_TW |
dc.description.abstract | Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis and hepatocellular carcinoma, especially in Taiwan. However, the detailed pathogenic mechanism remains unclear. It has been reported that core protein, a structure protein of HCV, regulates several cellular signaling pathways and transcriptional factors and induces hepatocellular carcinoma in transgenic mice. Thus, the interaction between core protein and its cellular targets may play important roles in the pathogenesis. Here, we characterize HCV core protein-mediated functional regulation of histone mehtyltransferases (HMTs). HMTs belong to members of chromatin modifiers that have to be recruited by specific transcription factors to the promoter region of genes to achieve transcriptional activation or repression.
By performing in vitro HMT assays, we found that core protein represses the HMT activity of arginine-specific HMTs (R-HMTs) CARM1 and PRMT1 as well as lysine-specific HMT (K-HMT) SET9 on their target sites of histone H3 or H4. In contrast, core protein increases SET9 activity on histone H1. Interestingly, core protein itself can be methylated by CARM1 and PRMT1 in the presence of histones. By using deletion mutants in HMT assays, amino acids 51 to 101 of core protein seem to be the inhibitory domain on HMT. Core protein has been reported to regulate functions of cellular transcription factors, such as p53 and NF-κB. DNA affinity protein assays show that core protein is recruited to the NF-κB binding site, and the promoter activities of certain NF-κB target genes, Cox-2, IL-8, MCP-1 and RANTES, are reduced in the presence of core protein in HuH-7 cells. CARM1 has been reported as a novel coactivator of NF-κB. Our GST pull-down assay shows that full length core interacts with endogenous NF-κB p65 subunit, CARM1 and SET9. Moreover, CARM1, PRMT1 and SET9 have been reported to be coactivators of p53. The promoter activity of another core protein target, p53 downstream gene p21, is also repressed in the presence of core protein in HuH-7 cells, and the result of chromatin immunoprecipitation shows that core protein reduces CARM1-mediated histone H3 dimethylation at R2 and R17 and PRMT1-mediated histone H4 R3 dimethylation on p21 promoter in HuH-7 cells. Taken together, HCV core protein-mediated downregulation of NF-κB and p53 target genes may likely occur through repression of activities of p53 and NF-κB coactivators, CARM1, PRMT1 and SET9 on histone H3/H4 methylation. Our study provides a novel pathway of core protein to modulate the activities of NF-κB and p53. And likely more HMT-regulated effects could be modulated by core protein. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:41:05Z (GMT). No. of bitstreams: 1 ntu-95-R93448002-1.pdf: 3500729 bytes, checksum: d66199dc85dcfc264a9f513f4c951438 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | Abstract………………………………………………………………1
中文摘要………………………………………………………………3 Introduction…………………………………………………………5 Hepatitis C virus is an important human pathogen…………5 Core protein may contribute to HCV pathogenesis……………6 1. Core protein has three isoforms……………………………6 2. Core protein interacts with several cellular proteins…………7 3. Core protein regulates the activity of transcription factors……………8 Histones can be post-translationally modified………………9 1. Histone acetylation and methylation are keys to gene regulation……………10 2. Hsitone methyltransferases, CARM1, PRMT1 and SET9 are coactivators……………………………………………10 3. Histone modifiers are regulated by viral proteins……12 Study Purposes……………………………………………………14 Materials and Methods………………………………………………15 Cell culture and transfections…………………………………15 Plasmids and antibodies……………………………………………15 Purification of GST-fusion HCV core protein…………………17 Purification of His-tagged HPV E6 and E7 protein…………18 GST pull-down assay…………………………………………………19 In vitro histone methyltransferase assay……………………19 Preparation of cytoplasmic and nuclear fractions…………20 DNA affinity protein assay………………………………………21 Luciferase Assay……………………………………………………22 Chromatin immunoprecipitation……………………………………22 Results…………………………………………………………………24 GST-fusion HCV core protein and its deletion mutants are successfully purified………24 HCV core protein regulates CARM1 activity……………………24 HCV core protein regulates PRMT1 activity……………………26 HCV core protein regulates SET9 activity……………………26 Core protein regulates NF-κB activity possibly via HMT inhibition……………………28 Core protein reduces histone arginine dimethylation on p21 promoter in HuH-7 cells……………………………………………30 Discussion……………………………………………………………32 HCV core protein regulates HMT activity with specificity…………32 Histone H1 might be a novel target of SET9…………………33 Amino acids 51 to 101 of core inhibit CARM1-, PRMT1- and SET9-mediated H3/H4 methylation…………………………………34 The trnafected core protein locates in the nucleus………34 Core protein may downregulate NF-κB activity through HMT inhibition……………35 A novel pathway of p53 downregulation by core protein……37 References……………………………………………………………39 Figure 1. HCV Core protein and its deletion mutants are successfully purified……..49 Figure 2. HCV core protein inhibits the HMT activity of CARM1 on histone H3 and core itself is methylated by CARM1…………………………………………………50 Figure 3. HCV core protein inhibits the HMT activity of PRMT1 on histone H4 and is methylated by PRMT1……………………………………………………………….51 Figure 4. HCV core protein inhibits the HMT activity of SET9 on histone H3 and increases the HMT activity on Histone H1……………………………………………52 Figure 5. HPV type 11, 16 and 18 E6 protein regulate the activities of HMTs…………53 Figure 6. HPV type 16 and 18 E7 protein regulate the activities of HMTs………54 Figure 7. Regulation of NF-κB activity by HCV core protein…………………55 Figure 8. Regulation of p53 activity by HCV core protein………………………56 Table 1. Summary of the in vitro HMT assay…………………57 | |
dc.language.iso | en | |
dc.title | C型肝炎病毒核心蛋白調控組蛋白甲基化酵素及其下游基因表現之分子機制探討 | zh_TW |
dc.title | Functional Regulation of Histone Methyltransferases and the Downstream Genes by HCV Core Protein | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 阮麗蓉(Li-Jung Juan),吳妍華(Yan-Hwa Wu Lee),施修明(Hsiu-Ming Shih),李芳仁(Fang-Jen Lee) | |
dc.subject.keyword | C型肝炎,核心蛋白,組蛋白甲基化酵素, | zh_TW |
dc.subject.keyword | hepatitis C virus,HCV,core protein,histone methyltransferase, | en |
dc.relation.page | 57 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-19 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
顯示於系所單位: | 分子醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 3.42 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。